TRX585
TRX585 is a humanised anti-immunoglobulin-like transcript 5 (ILT5) monoclonal antibody. TRX585 has a potent immunoregulatory activity. TRX585 significantly activates human T cells and upregulates NKG2D and Fas ligand, followed by enhancing antitumor activity with potent cytotoxicity. TRX585 can be used for viral infections and malignancies research[1].
Product Specifications
UNSPSC
12352203
Target
C-type Lectin-like Receptors (CTLRs)
Related Pathways
Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Inflammation/Immunology
References & Citations
[1]Apostolou I, et al. Immunoregulatory properties of TRX585, a novel monoclonal antibody specific for immunoglobulin-like transcript 5[J]. Journal of Clinical Oncology, 2010, 28 (15_suppl) : e13107-e13107.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A00382-1-Dylight488 100 µg
Anti-Cdc20 Antibody Picoband® (Dylight488 Conjugate)
Sign In for Pricing
View Details MBS6180390-01 0.1 mL
IPF1 (Pancreatic and duodenal Homeobox 1, GSF, IDX-1, IPF1, IUF1, MODY4, PDX-1, STF-1) (HRP)
Sign In for Pricing
View Details